Daré Bioscience gets Nasdaq notice after shares trade below $1 minimum bid price

• Daré Bioscience received a Nasdaq notice for failing the $1.00 minimum bid price rule after 30 consecutive business days below $1.00.
• Nasdaq set a 180-day compliance window through March 29, 2027; the stock remains listed during this period.
• Compliance requires a closing bid price of at least $1.00 for at least 10 consecutive business days.
• Failure to regain compliance by the deadline could trigger a delisting notice; a reverse stock split is among potential cures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dare Bioscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001401914-26-000052), on October 02, 2026, and is solely responsible for the information contained therein.